DEPRODONE

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C21H28O4
Molecular Weight	344.4446
Optical Activity	UNSPECIFIED
Defined Stereocenters	7 / 7
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[H][C@@]12CC[C@](O)(C(C)=O)[C@@]1(C)C[C@H](O)[C@@]3([H])[C@@]2([H])CCC4=CC(=O)C=C[C@]34C

InChI

InChIKey=KQZSMOGWYFPKCH-UJPCIWJBSA-N

InChI=1S/C21H28O4/c1-12(22)21(25)9-7-16-15-5-4-13-10-14(23)6-8-19(13,2)18(15)17(24)11-20(16,21)3/h6,8,10,15-18,24-25H,4-5,7,9,11H2,1-3H3/t15-,16-,17-,18+,19-,20-,21-/m0/s1

HIDE SMILES / InChI

Description
Sources: http://www.rad-ar.or.jp/siori/english/kekka.cgi?n=32407

Deprodone is a steroid that was approved in Japan for the treatment of inflammatory skin disorders. The drug is marketed under the name Eclar and contains 0.3% of the prodrug, deprodone propionate.

Approval Year

Conditions

Condition	Modality	Targets	Highest Phase	Product
Inflammatory skin diseases 5 Sources: http://www.rad-ar.or.jp/siori/english/kekka.cgi?n=32407	Primary		Approved 8429	ECLAR Approved Use It is usually used to treat eczema, dermatitis, drug eruption, insect sting, prurigo, psoriasis, erythroderma, erythema, palmoplanter pustulosis, alopecia areata, etc.

Patents

Sample Use Guides

In Vivo Use Guide

Deprodone (ointment or cream containing 0.3% deprodone propionate) is applied to the affected area, once to several times a day.

Route of Administration: Topical

In Vitro Use Guide

Unknown

Name

Type

Language

DEPRODONE

Official Name

English

DEPRODONE [MART.]

Common Name

English

Deprodone [WHO-DD]

Common Name

English

deprodone [INN]

Common Name

English

11.BETA.,17-DIHYDROXYPREGNA-1,4-DIENE-3,20-DIONE

Systematic Name

English

PREDNISOLONE ACETATE IMPURITY D [EP IMPURITY]

Common Name

English

11.BETA.,17-DIHYDROXYPREGNA-1,4-DIENE3,20-DIONE

Systematic Name

English

PREGNA-1,4-DIENE-3,20-DIONE, 11,17-DIHYDROXY-, (11.BETA.)-

Systematic Name

English

DESOLONE

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C521